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Ibrahim Etem Celik, MD 1 We thank Kundi et al 1 for their interest in our article entitled Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare Metal Stent. 2 In our study, we assessed the relationship between preprocedural serum albumin (SA) levels and in-stent restenosis (ISR) after coronary stenting with bare metal stent (BMS) in patients with stable angina pectoris, and we found that SA is an independent predictor of ISR. In the study, we mainly focused on the role of SA in the prediction of ISR, and we discussed several underlying mechanisms to explain our results. We mentioned that in particular, increased inflammatory activity may be an important mechanism for developing ISR, and we also indicated that elevated preprocedural serum levels of inflammatory biomarkers are related to higher risk of ISR after BMS implantation such as the neutrophil to lymphocyte ratio and high-sensitivity C-reactive protein (hsCRP) levels. 3, 4 In this regard, hsCRP, the most commonly used inflammatory biomarker, was included in the multivariate logistic regression analysis, and we also analyzed the correlation between hsCRP and SA levels. We found a significant inverse correlation between SA and hsCRP levels in the study cohort (r ¼ À0.169, P ¼ .008). However, we agree with the comment that the other inflammatory biomarkers should be included in the multivariate logistic regression analysis for identifying other independent predictors of ISR. These markers could provide complementary information. Further studies could better clarify the relationship between ISR and inflammatory biomarkers.
